1 Gladden, J. D., Chaanine, A. H. & Redfield, M. M. Heart Failure with Preserved Ejection Fraction. Annu. Rev. Med. 69, 65-79, doi:10.1146/annurev-med-041316-090654 (2018).
2 Wang, Z. et al. Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure. Am. J. Clin. Nutr. 92, 1369-1377, doi:10.3945/ajcn.2010.29885 (2010).
3 Ashrafian, H., Frenneaux, M. P. & Opie, L. H. Metabolic mechanisms in heart failure. Circulation 116, 434-448, doi:10.1161/CIRCULATIONAHA.107.702795 (2007).
4 Ferrannini, E., Mark, M. & Mayoux, E. CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis. Diabetes Care 39, 1108-1114, doi:10.2337/dc16-0330 (2016).
5 Kashiwaya, Y. et al. A ketone ester diet increases brain malonyl-CoA and Uncoupling proteins 4 and 5 while decreasing food intake in the normal Wistar Rat. J. Biol. Chem. 285, 25950-25956, doi:10.1074/jbc.M110.138198 (2010).
6 Sato, K. et al. Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J. 9, 651-658, doi:10.1096/fasebj.9.8.7768357 (1995).
7 Veech, R. L. Ketone esters increase brown fat in mice and overcome insulin resistance in other tissues in the rat. Ann. N. Y. Acad. Sci. 1302, 42-48, doi:10.1111/nyas.12222 (2013).
8 Nielsen, R. et al. Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients. Circulation 139, 2129-2141, doi:10.1161/CIRCULATIONAHA.118.036459 (2019).
9 Zhang, Y. et al. Mitochondrial pyruvate carriers are required for myocardial stress adaptation. Nat. Metab. 2, 1248-1264, doi:10.1038/s42255-020-00288-1 (2020).
10 Deng, Y. et al. Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF. Circ. Res. 128, 232-245, doi:10.1161/circresaha.120.317933 (2021).
11 Borlaug, B. A., Nishimura, R. A., Sorajja, P., Lam, C. S. P. & Redfield, M. M. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ. Heart Fail. 3, 588-595, doi:10.1161/CIRCHEARTFAILURE.109.930701 (2010).
12 Eisman, A. S. et al. Pulmonary Capillary Wedge Pressure Patterns During Exercise Predict Exercise Capacity and Incident Heart Failure. Circ. Heart Fail. 11, e004750, doi:10.1161/CIRCHEARTFAILURE.117.004750 (2018).
13 Schiattarella, G. G. et al. Nitrosative stress drives heart failure with preserved ejection fraction. Nature 568, 351-356, doi:10.1038/s41586-019-1100-z (2019).
14 Abel, E. D. Glucose transport in the heart. Front. Biosci. 9, 201-215, doi:10.2741/1216 (2004).
15 Pettersen, I. K. N. et al. Upregulated PDK4 expression is a sensitive marker of increased fatty acid oxidation. Mitochondrion 49, 97-110, doi:10.1016/j.mito.2019.07.009 (2019).
16 Longo, N., Frigeni, M. & Pasquali, M. Carnitine transport and fatty acid oxidation. Biochim. Biophys. Acta 1863, 2422-2435, doi:10.1016/j.bbamcr.2016.01.023 (2016).
17 Neubauer, S. et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96, 2190-2196, doi:10.1161/01.cir.96.7.2190 (1997).
18 Phan, T. T. et al. Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. J. Am. Coll. Cardiol. 54, 402-409, doi:10.1016/j.jacc.2009.05.012 (2009).
19 Shimazu, T. et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab. 12, 654-661, doi:10.1016/j.cmet.2010.11.003 (2010).
20 Nogueiras, R. et al. Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiol. Rev. (2012).
21 Bach, A. Oxaloacetate deficiency in MCT-induced ketogenesis. Arch. Int. Physiol. Biochim. 86, 1133-1142, doi:10.3109/13813457809055968 (1978).
22 Ingwall, J. S., Friedrich, J. & Nascimben, L. Does Decreased Energy Supply Contribute to Heart Failure? The Role of the Creatine Kinase System. Developments in Cardiovascular Medicine, 231-239, doi:10.1007/978-1-4613-1237-6_18 (1995).
23 Schulze, P. C. & Wu, J. M. F. Ketone bodies for the starving heart. Nat. Metab. 2, 1183-1185, doi:10.1038/s42255-020-00310-6 (2020).
24 Puchalska, P. & Crawford, P. A. Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. Cell Metab. 25, 262-284, doi:10.1016/j.cmet.2016.12.022 (2017).
25 Cotter, D. G., d'Avignon, D. A., Wentz, A. E., Weber, M. L. & Crawford, P. A. Obligate role for ketone body oxidation in neonatal metabolic homeostasis. J. Biol. Chem. 286, 6902-6910, doi:10.1074/jbc.M110.192369 (2011).
26 Bing, R. J. The metabolism of the heart. Trans. Am. Coll. Cardiol. 5, 8-14 (1955).
27 Garland, P. B., Newsholme, E. A. & Randle, P. J. Effect of fatty acids, ketone bodies, diabetes and starvation on pyruvate metabolism in rat heart and diaphragm muscle. Nature 195, 381-383, doi:10.1038/195381a0 (1962).
28 Hasselbaink, D. M., Glatz, J. F. C., Luiken, J. J. F. P., Roemen, T. H. M. & Van der Vusse, G. J. Ketone bodies disturb fatty acid handling in isolated cardiomyocytes derived from control and diabetic rats. Biochem. J. 371, 753-760, doi:10.1042/BJ20021617 (2003).
29 Jeffrey, F. M., Diczku, V., Sherry, A. D. & Malloy, C. R. Substrate selection in the isolated working rat heart: effects of reperfusion, afterload, and concentration. Basic Res. Cardiol. 90, 388-396, doi:10.1007/BF00788500 (1995).
30 Tardif, A. et al. Chronic exposure to beta-hydroxybutyrate impairs insulin action in primary cultures of adult cardiomyocytes. Am. J. Physiol. Endocrinol. Metab. 281, E1205-1212, doi:10.1152/ajpendo.2001.281.6.E1205 (2001).
31 Yan, J. et al. Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity. Circulation 119, 2818-2828, doi:10.1161/CIRCULATIONAHA.108.832915 (2009).
32 Goldman, D. S. Studies on the fatty acid oxidizing system of animal tissues. VII. The beta-ketoacyl coenzyme A cleavage enzyme. J. Biol. Chem. 208, 345-357 (1954).
33 Shukla, S. K. et al. HMGCS2 is a key ketogenic enzyme potentially involved in type 1 diabetes with high cardiovascular risk. Sci. Rep. 7, 4590, doi:10.1038/s41598-017-04469-z (2017).
34 Cook, G. A., Lavrentyev, E. N., Pham, K. & Park, E. A. Streptozotocin diabetes increases mRNA expression of ketogenic enzymes in the rat heart. Biochim. Biophys. Acta Gen. Subj. 1861, 307-312, doi:10.1016/j.bbagen.2016.11.012 (2017).
35 Walker, M. A. & Tian, R. NAD(H) in mitochondrial energy transduction: implications for health and disease. Curr. Opin. Physiol. 3, 101-109, doi:10.1016/j.cophys.2018.03.011 (2018).
36 Sundaresan, N. R. et al. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J. Clin. Invest. 119, 2758-2771, doi:10.1172/JCI39162 (2009).
37 Koentges, C. et al. SIRT3 deficiency impairs mitochondrial and contractile function in the heart. Basic Res. Cardiol. 110, 36, doi:10.1007/s00395-015-0493-6 (2015).
38 Pillai, V. B., Sundaresan, N. R., Jeevanandam, V. & Gupta, M. P. Mitochondrial SIRT3 and heart disease. Cardiovasc. Res. 88, 250-256, doi:10.1093/cvr/cvq250 (2010).
39 Murashige, D. et al. Comprehensive quantification of fuel use by the failing and nonfailing human heart. Science 370, 364-368, doi:10.1126/science.abc8861 (2020).
40 Voros, G. et al. Increased Cardiac Uptake of Ketone Bodies and Free Fatty Acids in Human Heart Failure and Hypertrophic Left Ventricular Remodeling. Circ. Heart Fail. 11, e004953, doi:10.1161/CIRCHEARTFAILURE.118.004953 (2018).
41 McCommis, K. S. et al. Nutritional modulation of heart failure in mitochondrial pyruvate carrier-deficient mice. Nat. Metab. 2, 1232-1247, doi:10.1038/s42255-020-00296-1 (2020).
42 Karwi, Q. G., Uddin, G. M., Ho, K. L. & Lopaschuk, G. D. Loss of Metabolic Flexibility in the Failing Heart. Front. Cardiovasc. Med. 5, 68, doi:10.3389/fcvm.2018.00068 (2018).
43. Schnelle, M. et al. Echocardiographic evaluation of diastolic function in mouse models of heart disease. J. Mol. Cell. Cardiol. 114, 20–28 (2018).
44. van Dijk, T. H. et al. A novel approach to monitor glucose metabolism using stable isotopically labelled glucose in longitudinal studies in mice. Lab. Anim. 47, 79–88 (2013).
45. Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985).
46. Lal, S. et al. Best Practice BioBanking of Human Heart Tissue. Biophys. Rev. 7, 399–406 (2015).
47. Mamidi, R. et al. Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior and Force Generation in Failing Human Myocardium. Circ. Heart Fail. 10, (2017).
48. Sequeira, V. et al. ADP-stimulated contraction: A predictor of thin-filament activation in cardiac disease. Proc. Natl. Acad. Sci. U. S. A. 112, E7003–12 (2015).
49. Harney, D. J. et al. Proteomic Analysis of Human Plasma during Intermittent Fasting. J. Proteome Res. 18, 2228–2240 (2019).
50. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008).
51. Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteomics 13, 2513–2526 (2014).
52. Effect of chronic exercise in healthy young male adults: a metabolomic analysis.
Yen Chin Koay, Kelly Stanton, Vivian Kienzle, Mengbo Li, Jean Yang, David S. Celermajer, John F. O’Sullivan. Cardiovasc. Res. 2021 Jan 21;117(2):613-622.
53. Koay, Y. C. et al. Ingestion of resistant starch by mice markedly increases microbiome-derived metabolites. FASEB J. 33, 8033–8042 (2019).
54. Kiyonami, R., Peake, D. A., Liu, X. & Huang, Y. in LIPID MAPS Annual Meeting. 12-13.
55. Peake, D. A., Kiyonami, R., Yokoi, Y., Fukamachi, Y. & Huang, Y. in ASMS annual meeting, Saint Louis, MO, 31st May–4th June.